| Name | Title | Contact Details |
|---|
Eigen is a Grass Valley, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Gradworks-Lifecycle marketing and Education is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Cleveland Medical Devices is a Cleveland, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
"Eleven uses its proprietary technology platform to create first-of-a-kind protein therapeutics to address unmet needs for ophthalmic diseases. Proteins are able to modulate inflammatory cytokines, key targets in ocular disease that have been difficult to access with conventional therapeutic approaches. A significant untapped opportunity exists for protein therapeutics to address ophthalmic diseases, and Eleven is applying its advanced protein technology and expertise to develop innovative medicines for patients suffering from ocular diseases. Eleven`s team of industry veterans has deep experience in understanding protein science and biologic drug development, designing and conducting clinical trials and, most importantly, applying specific expertise in ophthalmic disease to create novel ocular therapeutics to treat unmet medical needs. Eleven has developed a proprietary pipeline of ophthalmic drug candidates derived from the company`s innovative AMP-Rx protein engineering technology. The company`s initial product candidates are focused on targeting inflammatory cytokines and key targets of ocular disease by blocking the cytokines and modulating the biological processes that drive ocular disease. Current pipeline opportunities include ocular surface diseases such as dry eye disease (DED) and allergic conjunctivitis (AC), and back of the eye diseases such as diabetic macular edema (DME) and uveitis. In addition, Eleven’s proprietary technology has been utilized to prolong the intravitreal half-life of our pipeline products. Beyond its internal drug development programs, Eleven works with collaborators, such as ThromboGenics, to apply its innovative protein therapeutic design capabilities to engineer and develop biotherapeutic products for additional therapeutic targets. EBI-005, Eleven`s lead product candidate, is a novel interleukin-1 (IL-1) receptor antagonist in Phase 3 clinical development as one of the first topically administered proteins for the treatment of DED and AC, two inflammatory diseases at the surface of the eye."
Aaptiv is a mobile fitness product that is reinventing the way people workout, with audio classes that combine the motivation of a professional trainer with an incredible playlist. From truly fun treadmill workouts to effective elliptical classes, and interval routines that burn major calories, start enjoying your cardio with Aaptiv. Our team is dedicated to the belief that high-quality fitness instruction should not be a privilege for a few, but a right for all. We don`t think of fitness as an end goal, but rather a tool that fuels a richer, more successful life. We are looking for team members who are excited and eager to support our members by building the world`s best audio fitness product!